Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-014816
Filing Date
2015-04-08
Accepted
2015-04-08 19:06:23
Documents
1
Period of Report
2015-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7844
  Complete submission text file 0001140361-15-014816.txt   9312
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELL GENESYS INC 500 FORBES BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
ANDO DALE G (Reporting) CIK: 0001202278 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 15760083